Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FQ94Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,338
Award facts
- Contract value 100% obligated
- $16,337.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $16,337.95 to supply Zepbound (semaglutide) 10 mg/0.5 mL pen injections, with an ultimate completion date of November 13, 2025. This delivery order represents a non-set-aside, competitively awarded contract utilizing firm fixed pricing. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a child contract, this delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's substantial DLA IDC enables it to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Zepbound reflects AmerisourceBergen's role within the DLA's pharmaceutical supply chain, fulfilling ongoing medical requirements for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FQ94Z?
SPE2DB26FQ94Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FQ94Z worth?
The government has obligated $16,338 on SPE2DB26FQ94Z.
Is contract SPE2DB26FQ94Z an order under another contract?
Yes. SPE2DB26FQ94Z is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ94Z competed?
The extent of competition for SPE2DB26FQ94Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award